SEMA3A and breast cancer: Similar to these findings, Beetch et al. [298] confirmed the anticancer characteristics of PTS in addition to other mechanisms such as epigenetic activation of the tumor suppressor gene SEMA3A in breast cancer cells, decreased occupancy of DNMT3A and increased that of nuclear factor 1C within this gene promoter.